RFK Jr. Directs CDC to Alter Stance on Vaccine-Autism Link

Got story updates? Submit your updates here. ›

Robert F. Kennedy Jr., a high-ranking health official, has directed the Centers for Disease Control and Prevention (CDC) to modify its public stance on the potential link between vaccines and autism. The CDC's website now states that the claim 'vaccines do not cause autism' is not evidence-based, as studies have not definitively ruled out a connection, particularly with certain infant vaccines. This shift has sparked widespread alarm among public health experts who view it as an endorsement of misinformation that could undermine vaccination efforts.

Why it matters

The debate around vaccines and autism has long been contentious, with significant implications for public health. Kennedy's actions, coming from a position of authority, could erode trust in vaccines and lead to decreased vaccination rates, potentially resulting in the resurgence of preventable diseases. This raises questions about the balance between scientific certainty and transparency in public health messaging.

The details

Kennedy argues that while large-scale studies on the measles, mumps, and rubella (MMR) vaccine and the mercury-based preservative thimerosal haven't established a connection to autism, crucial gaps remain in vaccine safety science. He asserts that the blanket statement that vaccines are fully tested and proven safe is untrue, and he is particularly concerned about the potential link between autism and the hepatitis B vaccine or the DTaP shot (diphtheria, tetanus, and pertussis) given during infancy. However, global health organizations like the World Health Organization and the European Centre for Disease Prevention and Control have consistently affirmed that extensive research demonstrates no causal link between vaccines and autism.

• In a recent interview with The New York Times, Kennedy stated that he instructed the CDC to modify its public-facing information regarding vaccines and autism.
• A revamped advisory committee is scheduled to convene soon to discuss new recommendations for the hepatitis B vaccine, potentially adding fuel to this ongoing debate.

What they’re saying

What’s next

A revamped advisory committee is scheduled to convene soon to discuss new recommendations for the hepatitis B vaccine, potentially adding fuel to this ongoing debate.